Treatment of stage II non-small cell lung cancer

Chest

Volumn 123, Issue 1 SUPPL., 2003, Pages 188S-201S

  Scott, Walter J ^a,b   Howington, John ^c   Movsas, Benjamin ^b  

^a Section of Interventional Pulmonology and Thoracic Oncology   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Bronchogenic; Carcinoma; Chemotherapy; Guidelines; Lung; Neoplasm; Neoplasms; Practice guidelines; Radiotherapy; Staging; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MITOMYCIN; PACLITAXEL; PLATINUM; UFT; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMMUNOTHERAPY; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; META ANALYSIS; MORBIDITY; MULTIMODALITY CANCER THERAPY; PEROPERATIVE CARE; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037250294     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.1_suppl.188S     Document Type: Review

References (52)

1. AJCC cancer staging manual, 5th ed. In: Greene FL, Page DL, Flemming ID, et al, eds. Philadelphia, PA: Lippincott-Raven Press; 1997
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
3. Inoue K, Sato M Fujimura S, et al. Prognostic assessment of 1310 patients with non-small cell lung cancer who underwent complete resection from 1980-1993. J Thorac Cardiovasc Surg 1998; 116:407-411
4. van Rens MT, de la Riviere AB, Elbers HR, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000; 117:374-379
5. Adebonojo S, Bowser A, Moritz D, et al. Impact of revised stage classification of lung cancer on survival: a military experience. Chest 1999; 115:1507-1513
6. Jassem J, Skokowski J, Dziadziusko R, et al. Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. J Thorac Cardiovasc Surg 2000; 119:1141-1146
7. Downey RJ, Martini N, Rusch VW, et al. Extent of chest wall invasion and survival in patients with lung cancer. Ann Thorac Surg 1999; 68:188-193
8. Vrdoljak E, Mise K, Sapunar D, et al. Survival analysis of untreated patients with non-small cell lung cancer. Chest 1994; 106:1797-1800
9. Elia S, Griffo S, Gentile M, et al. Surgical treatment of lung cancer invading the chest wall: a retrospective analysis of 110 patients. Eur J Cardiothorac Surg. 2001; 20:356-360
10. Yano T, Yokoyama H, Inoue T, et al. Surgical results and prognostic factors of pathologic N1 disease in non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg 1994; 107:1398-1402
11. van Velzen E, Snijder RJ, de la Riviere AB, et al. Lymph node type as a prognostic factor for survival in T2N1M0 non-small cell lung carcinoma. Ann Thorac Surg 1997; 63:1436-1440
12. Riquet M, Manac'h D, Le Pimpec-Barthes F, et al. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg 1999; 67:1572-1576
13. Burt ME, Pomerantz AH, Bains MS, et al. Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am 1987; 67:987-1000
14. Pitz CCM, de la Riviere AB, Elbers HRJ, et al. Results of resection of T3 non-small cell lung cancer invading the mediastinum or main bronchus. Ann Thorac Surg 1996; 62:1016-1020
15. Weksler B, Bains M, Burt M, et al. Resection of lung cancer invading the diaphragm. J Thorac Cardiovasc Surg 1997; 114:500-501
16. Martini N, Yellin A, Ginsberg RJ, et al. Management of non-small cell lung cancer with direct mediastinal involvement. Ann Thorac Surg 1994; 58:1447-1451
17. Gaissert HA, Mathisen DJ, Moncure AC, et al. Survival and function after sleeve lobectomy for lung cancer. J Thorac Cardiovasc Surg 1996; 111:948-953
18. Yoshino I, Yokoyama H, Yano T, et al. Comparison of the surgical results of lobectomy with bronchoplasty and pneumonectomy for lung cancer. J Surg Oncol 1997; 64:32-35
19. Okado M, Yamagashi H, Satake S, et al. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. J Thorac Cardiovasc Surg 2000; 119:814-819
20. Weisenburger T. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung: N Engl J Med 1986; 315:1377-1381
21. Stephens RJ. The role of post-operative radiotherapy in non-small cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2 N1-2 M0 disease. MRC Lung Cancer Working Party. Br J Cancer 1996; 74:632-639
22. Dautzenberg B, Arriagada R, Chammard A, et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer 1999; 86:265-273
23. Feng Q, Wang M, Wang L, et al. A study of postoperative radiotherapy in patients with nonsmall cell lung cancer: a randomized trial. Int J Radiol Oncol Biol Phys 2000; 47:925-929
24. Mayer R, Smolle-Jeuttner F-M, Szolar D, et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 1997; 112:954-959
25. Stewart LA. Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998; 352:257-263
26. Movsas B. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer: part 1. Oncology 2001; 15:1549-1558
27. Lee J, Machtay M, Shrager J, et al. Postoperative radiotherapy (XRT) for non-small cell lung carcinoma (NSCLC) does not lead to an excess rate of intercurrent death [abstract]. Proc Am Soc Clin Oncol 1999; 18:472
28. Holmes EC. Surgical adjuvant therapy for stage I and stage III adenocarcinoma and large cell undifferentiated carcinoma. Chest 1994; 106(suppl):293S-296S
29. Stewart LA. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-Small Cell Lung Cancer Collaborative Group. BMJ 1995; 311-899-909
30. Dautzenberg B, Chastang C, Arriagada R, et al. Adjuvant radiotherapy vs combined sequential chemotherapy followed by radiotherapy in the treatment of nonsmall cell lung carcinoma. Cancer 1995; 76:779-786
31. Keller SM, Adak S, Wagner H, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small cell lung cancer. N Engl J Med 2000; 343:1217-1222
32. Pisters K, Ginsberg R, Giroux D, et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. J Thorac Cardiovasc Surg 2000; 119:429-439
33. Siegenthaler M, Pisters K, Merriman K, et al. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 2001; 71:1105-1112
34. Roberts J, Eustis C, Devore R, et al. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 2001; 72:885-888
35. Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small cell lung cancer. J Clin Oncol 2001; 20:247-253
36. Ratto GB, Piacenza G, Frola C, et al. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann Thorac Surg 1991; 51:182-188
37. Glazer HS, Duncan-Meyer J, Aronberg DJ, et al. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology 1985; 157:191-194
38. Pennes DR, Glazer Gm, Winbish KJ, et al. Chest wall invasion by lung cancer: limitations of CT evaluation. Am J Radiol 1985; 144:507-511
39. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178:705-713
40. Nakahashi H, Yasumoto K, Ishida T, et al. Results of surgical treatment of patients with T3 non-small cell lung cancer. Ann Thorac Surg 1988; 46:178-181
41. Pitz CC, Brutel de la Riviere A, Westermann C, et al. Surgical treatment of 125 patients with non-small cell lung cancer and chest wall involvement. Thorax 1996; 51:846-850
42. Ratto GB, Piacenza G, Musante F, et al. Chest wall involvement by lung cancer: Computed tomographic detection and results of operation. Ann Thorac Surg 1991; 51:182-188
43. Magdeleinat P, Alifano M, Benbrahem C, et al. Surgical treatment of lung cancer invading the chest wall: results and prognostic factors. Ann Thorac Surg 2001; 71:1094-1099
44. Albertucci M, DeMeester T, Rothberg M, et al. Surgery and the management of peripheral lung tumors adherent to the parietal pleura. J Thorac Cardiovasc Surg 1992; 103:8-12
45. Harpole DH Jr, Healey EA, DeCamp M Jr, et al. Chest wall invasive non-small cell lung cancer: patterns of failure and implications for a revised staging system. Ann Surg Oncol 1996; 3:261-269
46. Patterson GA, Ilves R, Ginsberg RJ, et al. The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma. Ann Thorac Surg 1982; 34:692-697
47. Piehler JM, Pairolero PC, Weiland LH, et al. Bronchogenic carcinoma with chest wall invasion: factors affecting survival following en bloc resection. Ann Thorac Surg 1982; 34:684-691
48. Dartevelle P, Khalife J, Chapelier A, et al. Tracheal sleeve pneumonectomy for bronchogenic carcinoma: report of 55 cases. Ann Thorac Surg 1988; 46:68-72
49. Vogt-Moykopf I, Fritz T, Meyer G, et al. Bronchoplastic and angioplastic operation in bronchial carcinoma: long term results of a retrospective analysis from 1073 to 1983. Intern Surg 1986; 71:211-220
50. Deslauriers J, Mehran RJ, Guimont C, et al. Staging and management of lung cancer: sleeve resection. World J Surg 1993; 17:712-718
51. Okada M, Tsubota N, Yoshimura M, et al. How should interlobar invasion be classified? Prognosis of resected T3 non-small cell lung cancer. Ann Thorac Surg 1999; 68:2049-2052
52. Staples CA, Muller NL, Miller R, et al. Mediastinal nodes in bronchogenic carcinoma: a comparison between CT and mediastinoscopy. Radiology 1988; 167:367-372